4//SEC Filing
Reine Allan 4
Accession 0001894562-25-000023
CIK 0001894562other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 7:44 PM ET
Size
5.4 KB
Accession
0001894562-25-000023
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-19+2,000,000→ 2,000,000 totalExercise: $1.33→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on May 19, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 7:44 PM ET
- Size
- 5.4 KB